Skip to main content
Back
IHHHF logo

IHH Healthcare Berhad

Data quality: 100%
Overbought
IHHHF
OTC Healthcare Medical - Care Facilities
$1.45
$0.00 (0.00%)
Mkt Cap: 12.81B
Day Range
$1.19 $1.45
52-Week Range
$1.19 $1.45
Volume
1
50D / 200D Avg
$1.45 / $1.32
Prev Close
$1.45

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 6.1 0.4
P/B 0.4 2.9
ROE % 6.9 3.7
Net Margin % 8.2 3.8
Rev Growth 5Y % 10.7 10.0
D/E 0.6 0.2

Key Takeaways

Revenue grew 10.66% annually over 5 years — strong growth
Earnings declined -21.10% over the past year
Generating 1.60B in free cash flow
P/E of 6.11 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.31%

Growth

Revenue Growth (5Y)
10.66%
Revenue (1Y)5.35%
Earnings (1Y)-21.10%
FCF Growth (3Y)-6.09%

Quality

Return on Equity
6.94%
ROIC5.22%
Net Margin8.16%
Op. Margin12.93%

Safety

Debt / Equity
0.58
Current Ratio0.58
Interest Coverage3.13

Valuation

P/E Ratio
6.11
P/B Ratio0.42
EV/EBITDA8.63
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 5.35% Revenue Growth (3Y) 10.77%
Earnings Growth (1Y) -21.10% Earnings Growth (3Y) -15.73%
Revenue Growth (5Y) 10.66% Earnings Growth (5Y) 3.00%
Profitability
Revenue (TTM) 25.69B Net Income (TTM) 2.10B
ROE 6.94% ROA 3.65%
Gross Margin 25.74% Operating Margin 12.93%
Net Margin 8.16% Free Cash Flow (TTM) 1.60B
ROIC 5.22% FCF Growth (3Y) -6.09%
Safety
Debt / Equity 0.58 Current Ratio 0.58
Interest Coverage 3.13 Dividend Yield 0.02%
Valuation
P/E Ratio 6.11 P/B Ratio 0.42
P/S Ratio 0.50 PEG Ratio -1.24
EV/EBITDA 8.63 Dividend Yield 0.02%
Market Cap 12.81B Enterprise Value 28.68B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 25.69B 24.38B 20.94B 17.99B 17.13B
Net Income 2.10B 2.66B 2.95B 1.55B 1.86B
EPS (Diluted) 0.24 0.30 0.34 0.17 0.20
Gross Profit 6.61B 17.56B 14.70B 12.49B 11.99B
Operating Income 3.32B 4.03B 4.16B 2.69B 3.14B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 57.49B 56.76B 51.25B 48.47B 45.51B
Total Liabilities 23.46B 22.85B 18.90B 19.31B 18.23B
Shareholders' Equity 30.24B 30.14B 29.11B 26.19B 24.58B
Total Debt 17.46B 14.78B 10.05B 10.83B 10.87B
Cash & Equivalents 1.59B 1.51B 2.36B 1.83B 5.02B
Current Assets 6.64B 6.87B 6.71B 8.28B 8.53B
Current Liabilities 11.37B 9.58B 7.46B 7.26B 6.05B

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#279 of 616
38

Recent Activity

Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026